Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
CONTEXT: Metformin is widely prescribed to pregnant women with polycystic ovary syndrome (PCOS) in an attempt to reduce pregnancy complications. Metformin is not approved for this indication, and evidence for this practice is lacking. OBJECTIVES: Our objective was to test the hypothesis that metformin, from first trimester to delivery, reduces pregnancy complications in women with PCOS. DESIGN AND SETTING: We conducted a randomized, placebo-controlled, double-blind, multicenter study at 11 secondary care centers. PARTICIPANTS: The participants were 257 women with PCOS, in the first trimester of pregnancy, aged 18-42 yr. INTERVENTION: We randomly assigned 274 singleton pregnancies (in 257 women) to receive metformin or placebo, from first trimester to delivery. MAIN OUTCOME MEASURES: The prevalence of preeclampsia, gestational diabetes mellitus, preterm delivery, and a composite of these three outcomes is reported. RESULTS: Preeclampsia prevalence was 7.4% in the metformin group and 3.7% in the placebo group (3.7%; 95% CI, -1.7-9.2) (P=0.18). Preterm delivery prevalence was 3.7% in the metformin group and 8.2% in the placebo group (-4.4%; 95%, CI, -10.1-1.2) (P=0.12). Gestational diabetes mellitus prevalence was 17.6% in the metformin group and 16.9% in the placebo group (0.8%; 95% CI, -8.6-10.2) (P=0.87). The composite primary endpoint prevalence was 25.9 and 24.4%, respectively (1.5%; 95% CI, -8.9-11.3) (P=0.78). Women in the metformin group gained less weight during pregnancy compared with those in the placebo group. There was no difference in fetal birth weight between the groups. CONCLUSIONS: Metformin treatment from first trimester to delivery did not reduce pregnancy complications in PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized, double-blind, controlled trials comparing metformin with other therapies for ovulation induction in individuals with polycystic ovary syndrome have not demonstrated benefit in preventing spontaneous abortion or GDM (91),”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [91]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Knochenhauer, E. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,127
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063971 · Cited by 1,027
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome
Boomsma, C. M., Eijkemans, M. J. C., Hughes, E. G., Visser, G. H. A., Fauser, B. C. J. M., & Macklon, N. S. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml036 · Cited by 852
Cited by
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
“higher incidence of gastrointestinal disturbance, but no serious maternal or fetal adverse effects (76, 254, 274).”
BackgroundBalen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw025 · Cited by 705
Pregnancy complications in women with polycystic ovary syndrome
Palomba, S., de Wilde, M. A., Falbo, A., Koster, M. P. H., La Sala, G. B., & Fauser, B. C. J. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv029 · Cited by 691
Gestational diabetes mellitus: an updated overview
Chiefari, E., Arcidiacono, B., Foti, D., & Brunetti, A. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0607-5 · Cited by 522
“Neverthless, this was not confirmed in another trial, in which metformin was initiated during pregnancy and not in the preconception period [90].”
Result15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
Metformin versus placebo in obese pregnant women without diabetes mellitus
Syngelaki, A., Nicolaides, K. H., Balani, J., Hyer, S., Akolekar, R., Kotecha, R., Pastides, A., & Shehata, H. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509819 · Cited by 394
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
Thompson, D., Berger, H., Feig, D., Gagnon, R., Kader, T., Keely, E., Kozak, S., Ryan, E., Sermer, M., & Vinokuroff, C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.044 · Cited by 377
Consensus on women's health aspects of polycystic ovary syndrome (PCOS)
The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group, Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, H., Chang, R. J., Yildiz, B. O., et al. (2012) · Human Reproduction · doi:10.1093/humrep/der396 · Cited by 366
“Data in relation to the risk of miscarriage in women with PCOS are conflicting, although miscarriage rates are generally thought to be comparable with other subfertile populations (Tang et al., 2010; Vanky et al., 2010).”
Result13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s013 · Cited by 332
“Randomized, double-blind, controlled trials comparing metformin with other therapies for ovulation induction in women with polycystic ovary syndrome havenot demonstratedbenefit in preventing spontaneous abortion or GDM (42), and there is no evidence-based need to continuemetformin in such patients once”
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Randeva, H. S., Tan, B. K., Weickert, M. O., Lois, K., Nestler, J. E., Sattar, N., & Lehnert, H. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1003 · Cited by 322
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
Obesity and PCOS: Implications for Diagnosis and Treatment
Legro, R. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1328878 · Cited by 280
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s014 · Cited by 268
14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s014 · Cited by 265
“trials comparing metformin with other therapies for ovulation induction in women with polycystic ovary syndrome have not demonstrated benefit in preventing spontaneous abortion or GDM (55), and there is no evidence-based need to continue metformin in such patients once pregnancy has been confirmed (56–58).”
MethodChiswick, C., Reynolds, R. M., Denison, F., Drake, A. J., Forbes, S., Newby, D. E., Walker, B. R., Quenby, S., Wray, S., Weeks, A., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00219-3 · Cited by 260
“Birthweight was a secondary outcome in one study (Vanky et al, 2010), in which pregnant women with a history of polycystic ovary syndrome were randomly assigned to receive metformin or placebo.”
Result15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
Feig, D. S., Donovan, L. E., Zinman, B., Sanchez, J. J., Asztalos, E., Ryan, E. A., Fantus, I. G., Hutton, E., Armson, A. B., Lipscombe, L. L., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30310-7 · Cited by 234
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232
Should all women with PCOS be treated for insulin resistance?
Marshall, J. C., & Dunaif, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.036 · Cited by 217
“Further, a recent RCT showed that metformin treatment from the first trimester through pregnancy did not reduce pregnancy complications or alter birth weight in PCOS (50).”
BackgroundBahri Khomami, M., Joham, A. E., Boyle, J. A., Piltonen, T., Silagy, M., Arora, C., Misso, M. L., Teede, H. J., & Moran, L. J. (2019) · Obesity Reviews · doi:10.1111/obr.12829 · Cited by 211
“This likely aggravates sex hormone imbalances that contribute to adverse pregnancy and birth outcomes through endometrial abnormalities like thickening the endometrium,108 dysregulating angiogenesis,92 and inducing a state of inflammation in endometrium94,109-111 and consequently impacting on implantation and placenta…”
ResultInfluentialHanem, L. G. E., Stridsklev, S., Júlíusson, P. B., Salvesen, Ø., Roelants, M., Carlsen, S. M., Ødegård, R., & Vanky, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02419 · Cited by 199
Self-citationPolycystic ovary syndrome throughout a woman’s life
Group of interest in Reproductive Endocrinology (GIER) of the Spanish Fertility Society (SEF), Bellver, J., Rodríguez-Tabernero, L., Robles, A., Muñoz, E., Martínez, F., Landeras, J., García-Velasco, J., Fontes, J., Álvarez, M., et al. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-1047-7 · Cited by 180
“recent randomized controlled trial in which this drug was compared with a placebo [119].”
Background13. Management of Diabetes in Pregnancy
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s016 · Cited by 179
“Randomized, double-blind, controlled trials comparing metformin with other therapies for ovulation induction in women with polycystic ovary syndrome have not demonstrated benefit in preventing spontaneous abortion or GDM (36), and there is no evidence-based need to continue metformin in such patients once pregnancy ha…”
Løvvik, T. S., Carlsen, S. M., Salvesen, Ø., Steffensen, B., Bixo, M., Gómez-Real, F., Lønnebotn, M., Hestvold, K. V., Zabielska, R., Hirschberg, A. L., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30002-6 · Cited by 176
Self-citationButalia, S., Gutierrez, L., Lodha, A., Aitken, E., Zakariasen, A., & Donovan, L. (2017) · Diabetic Medicine · doi:10.1111/dme.13150 · Cited by 170
D’Anna, R., Scilipoti, A., Giordano, D., Caruso, C., Cannata, M. L., Interdonato, M. L., Corrado, F., & Di Benedetto, A. (2013) · Diabetes Care · doi:10.2337/dc12-1371 · Cited by 166
Inositols: From Established Knowledge to Novel Approaches
Dinicola, S., Unfer, V., Facchinetti, F., Soulage, C. O., Greene, N. D., Bizzarri, M., Laganà, A. S., Chan, S.-Y., Bevilacqua, A., Pkhaladze, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910575 · Cited by 154
“Indeed, for the purposes of GDM prevention, earlier observational studies [65–67] suggested that metformin administration could be associated with lower risk of GDM development, but these results were not confirmed by subsequent trials [68].”
ResultCassina, M., Donà, M., Di Gianantonio, E., Litta, P., & Clementi, M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu022 · Cited by 143
“…an inappropriate control group (women exposed to metformin at the time of conception and until confirmation of pregnancy) (Batukan and Baysal, 2001; Vanky et al., 2004, 2010; Qublan and Malkawi, 2005; Thatcher and Jackson, 2006; Turner et al., 2006; Begum et al., 2009; Qublan et al., 2009;…”
BackgroundNaver, K., Grinsted, J., Larsen, S., Hedley, P., Jørgensen, F., Christiansen, M., & Nilas, L. (2014) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12558 · Cited by 141
Hanem, L. G. E., Salvesen, Ø., Juliusson, P. B., Carlsen, S. M., Nossum, M. C. F., Vaage, M. Ø., Ødegård, R., & Vanky, E. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30385-7 · Cited by 134
Self-citationPolycystic Ovary Syndrome: Update on Diagnosis and Treatment
Setji, T. L., & Brown, A. J. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.04.017 · Cited by 145
“78).(39) Thus, metformin does not appear to prevent pregnancy complications in women with polycystic ovary syndrome.”
Domecq, J. P., Prutsky, G., Mullan, R. J., Sundaresh, V., Wang, A. T., Erwin, P. J., Welt, C., Ehrmann, D., Montori, V. M., & Murad, M. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2374 · Cited by 115
Interventions for Preventing Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
Oostdam, N., van Poppel, M. N. M., Wouters, M. G. A. J., & van Mechelen, W. (2011) · Journal of Women's Health · doi:10.1089/jwh.2010.2703 · Cited by 114
“Piirainen et al. 33 and Luoto et al. 34 provided additional information about the Laitinen et al. intervention 22 ; Clapp 35,36 provided additional information for the earlier article 17 ; and Fougner et al. 37 provided additional information for the Vanky et al. article.”
InfluentialRisk of pre‐eclampsia in women taking metformin: a systematic review and meta‐analysis
Alqudah, A., McKinley, M. C., McNally, R., Graham, U., Watson, C. J., Lyons, T. J., & McClements, L. (2018) · Diabetic Medicine · doi:10.1111/dme.13523 · Cited by 114
Lautatzis, M.-E., Goulis, D. G., & Vrontakis, M. (2013) · Metabolism · doi:10.1016/j.metabol.2013.06.006 · Cited by 113
Gestational diabetes mellitus: does an effective prevention strategy exist?
Agha-Jaffar, R., Oliver, N. S., Johnston, D. G., & Robinson, S. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.88 · Cited by 129
Ganie, M. A., Khurana, M. L., Nisar, S., Shah, P. A., Shah, Z. A., Kulshrestha, B., Gupta, N., Zargar, M. A., Wani, T. A., Mudasir, S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1040 · Cited by 109
Sivalingam, V. N., Myers, J., Nicholas, S., Balen, A. H., & Crosbie, E. J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu037 · Cited by 108
“…a large Norwegian multicentre RCT found no improvement in these complications with continued use of metformin from late first trimester to delivery (Vanky et al., 2010), although there appeared to be a reduction in late miscarriage and preterm delivery rates, which is now the subject of a large…”
A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes
Barbour, L. A., Scifres, C., Valent, A. M., Friedman, J. E., Buchanan, T. A., Coustan, D., Aagaard, K., Thornburg, K. L., Catalano, P. M., Galan, H. L., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.06.013 · Cited by 101
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 176
Myo-inositol may prevent gestational diabetes in PCOS women
D’Anna, R., Di Benedetto, V., Rizzo, P., Raffone, E., Interdonato, M. L., Corrado, F., & Di Benedetto, A. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.633665 · Cited by 95
“Similar results were obtained in a larger multicenter study in which metformin was used [14]; whereas in the Katthab et al.”
BackgroundResultKalafat, E., Sukur, Y. E., Abdi, A., Thilaganathan, B., & Khalil, A. A. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19084 · Cited by 100
Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero
Rø, T. B., Ludvigsen, H. V., Carlsen, S. M., & Vanky, E. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2012.712319 · Cited by 85
“The strength of our study is that the study population was recruited from a randomized controlled trial where pregnant women with PCOS were given metformin or placebo.”
BackgroundSelf-citationOvulation induction in polycystic ovary syndrome: Current options
Legro, R. S. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.08.001 · Cited by 93
Cicero, A. F. G., Tartagni, E., & Ertek, S. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.31622 · Cited by 81
“Although recent studies with larger populations support the safety of metformin during pregnancy [50], the risk of macrosomia [51] and preeclampsia [52] is still not clear and there are also studies with conflicting results [53].”
ResultMetformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study
Brand, K. M. G., Saarelainen, L., Sõnajalg, J., Boutmy, E., Foch, C., Vääräsmäki, M., Morin-Papunen, L. C., Schlachter, J., CLUE Study Group, Hakkarainen, K. M., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002363 · Cited by 110
Kjøtrød, S., Carlsen, S. M., Rasmussen, P. E., Holst-Larsen, T., Mellembakken, J. R., Thurin‐Kjellberg, A., HaapaniemiKouru, K., Morin-Papunen, L. C., Humaidan, P., Sunde, A. L., et al. (2011) · Human Reproduction · doi:10.1093/humrep/der154 · Cited by 86
“Finally, during the study period metformin became more or less established as a ‘proven’ drug in the treatment of PCOS, making it progressively more difficult to include women with PCOS into a study with a 50% chance of getting placebo (Vanky et al., 2010).”
BackgroundSelf-citationMetformin's Effect on First-Year Weight Gain: A Follow-up Study
Carlsen, S. M., Martinussen, M. P., & Vanky, E. (2012) · Pediatrics · doi:10.1542/peds.2012-0346 · Cited by 83
Self-citationMetformin in Pregnancy: Mechanisms and Clinical Applications
Hyer, S., Balani, J., & Shehata, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071954 · Cited by 78
“The investigators found no difference in the primary outcome, a composite of preeclampsia, GDM and preterm delivery [47].”
Rees, D. A., Jenkins-Jones, S., & Morgan, C. L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2682 · Cited by 78
Placental STAT3 signaling is activated in women with polycystic ovary syndrome
Maliqueo, M., Sundstrom Poromaa, I., Vanky, E., Fornes, R., Benrick, A., Akerud, H., Stridsklev, S., Labrie, F., Jansson, T., & Stener-Victorin, E. (2015) · Human Reproduction · doi:10.1093/humrep/deu351 · Cited by 77
Self-citationEffects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis
Zeng, X.-L., Zhang, Y.-F., Tian, Q., Xue, Y., & An, R.-F. (2016) · Medicine · doi:10.1097/md.0000000000004526 · Cited by 76
“Insulin sensitizers, such as metformin, may be beneficial in dealing with PCOS.”
MethodResultInfluentialBahri Khomami, M., Joham, A. E., Boyle, J. A., Piltonen, T., Arora, C., Silagy, M., Misso, M. L., Teede, H. J., & Moran, L. J. (2019) · Obesity Reviews · doi:10.1111/obr.12832 · Cited by 75
“In this meta‐analysis, the prevalence of outcomes did not significantly change on exclusion of studies using metformin during pregnancy, which is consistent with prior literature on PTB and BW.82 Whilst a prior RCT reported women with PCOS who continued taking metformin during pregnancy had lower GWG,82 we had no data…”
ResultInfluentialof the Drug and Therapeutics Committee of the Pediatric Endocrine Society, Geller, D. H., Pacaud, D., Gordon, C. M., & Misra, M. (2011) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2011-9 · Cited by 72
“However, a recent large randomized study of more than 600 women reported no improvement in fertility (as assessed by live birth rates) with use of extended release metformin in women with PCOS compared with clomiphene [172,173].”
BackgroundTarry‐Adkins, J. L., Ozanne, S. E., & Aiken, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-88650-5 · Cited by 84
Pregnancy in polycystic ovary syndrome
Kamalanathan, S., Sahoo, J. P., & Sathyapalan, T. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.107830 · Cited by 79
“Vanky, et al. initially did a pilot study on metformin’s utility in pregnancy of PCOS women, which showed a reduced rate of severe pregnancy complications when it was taken throughout pregnancy.”
BackgroundInfluentialGHAZEERI, G. S., NASSAR, A. H., YOUNES, Z., & AWWAD, J. T. (2012) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01385.x · Cited by 67
“(46) [2010] Randomized, placebo-controlled, double-blind, multicenter study Rotterdam criteria 257 women with PCOS Adjusted for weight 1.”
BackgroundMethodInfluentialBahri Khomami, M., Boyle, J. A., Tay, C. T., Vanky, E., Teede, H. J., Joham, A. E., & Moran, L. J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13579 · Cited by 65
Self-citationSaadati, S., Mason, T., Godini, R., Vanky, E., Teede, H. J., & Mousa, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16422 · Cited by 117
Self-citationPregnancy complications in polycystic ovary syndrome patients
Katulski, K., Czyzyk, A., Podfigurna-Stopa, A., Genazzani, A. R., & Meczekalski, B. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2014.974535 · Cited by 62
“significant changes have been observed as for improving fertility and obtaining a better birth rate as compared with the group of PCOS patients who have not taken metformin [43,44].”
ResultCrisosto, N., Echiburú, B., Maliqueo, M. A., Pérez, V., de Guevara, A. L., Jessica Preisler, R., Sánchez, F., & Sir‐Petermann, T. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.10.002 · Cited by 68
Reyes-Muñoz, E., Castellanos-Barroso, G., Ramírez-Eugenio, B. Y., Ortega-González, C., Parra, A., Castillo-Mora, A., & De la Jara-Díaz, J. F. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.023 · Cited by 61
Metformin Therapy During Pregnancy
Feig, D. S., & Moses, R. G. (2011) · Diabetes Care · doi:10.2337/dc11-1153 · Cited by 57
“While the metformin-induced reduction in insulin resistance in women with PCOS should in theory also lower the risk of developing GDM, the limited results so far have been conflicting (16,17).”
ResultZhuo, Z., Wang, A., & Yu, H. (2014) · Journal of Diabetes Research · doi:10.1155/2014/381231 · Cited by 55
“27 Nawaz and Rizvi, 2010[27] CC P No description.”
BackgroundPalomba, S., Falbo, A., Russo, T., Rivoli, L., Orio, M., Cosco, A. G., Vero, R., Capula, C., Tolino, A., Zullo, F., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1971 · Cited by 51
van Weelden, W., Wekker, V., de Wit, L., Limpens, J., Ijäs, H., van Wassenaer-Leemhuis, A. G., Roseboom, T. J., van Rijn, B. B., DeVries, J. H., & Painter, R. C. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0479-0 · Cited by 51
Feng, L., Lin, X.-F., Wan, Z.-H., Hu, D., & Du, Y.-K. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1041906 · Cited by 50
“Though not all the controls got conception with metformin, two studies [24,25] were included after group discussion because of the strict design and implementation, limited randomized controlled trials and inter-class equilibration between study and control group.”
BackgroundMethodResultInfluentialArya, S., Hansen, K. R., Peck, J. D., & Wild, R. A. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.03.048 · Cited by 59
Li, R., Mai, T., Zheng, S., & Zhang, Y. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06700-3 · Cited by 60
“For the best interest of patients, especially concerned about strategies applied in real-world practice, we designed to continue metformin for all the patients after first 12 weeks during their trial of conception since metformin was considered as safe therapy in pregnant women [12, 43].”
BackgroundThe use of oral hypoglycaemic agents in pregnancy
Holt, R. I. G., & Lambert, K. D. (2014) · Diabetic Medicine · doi:10.1111/dme.12376 · Cited by 50
Velija-Ašimi, Z. (2013) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2013.2359 · Cited by 53
A Case Control Study of Diabetes During Pregnancy and Low Milk Supply
Riddle, S. W., & Nommsen‐Rivers, L. A. (2016) · Breastfeeding Medicine · doi:10.1089/bfm.2015.0120 · Cited by 52
Vanky, E., Nordskar, J., Leithe, H. L., Hjorth‐Hansen, A., Martinussen, M., & Carlsen, S. M. (2012) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2012.03449.x · Cited by 50
Self-citationPregnancy outcomes in women with polycystic ovarian syndrome
D’Alterio, M. N., Sigilli, M., Succu, A. G., GHISU, V., Laganà, A. S., Sorrentino, F., Nappi, L., Tinelli, R., & Angioni, S. L. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04758-4 · Cited by 53
Prevention of gestational diabetes mellitus: Where are we now?
Simmons, D. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12495 · Cited by 48
“Although early observational data suggested that GDM among women with PCOS was reduced with metformin [67], this was not confirmed by a large RCT from the first trimester [57] or a meta-analysis including the three studies from the same group [68].”
Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction
Petersen, K. B., Pedersen, N. G., Pedersen, A. T., Lauritsen, M. P., & Freiesleben, N. L. C. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.03.006 · Cited by 54
Efficacy and safety of metformin during pregnancy: an update
Paschou, S. Α., Shalit, A., Gerontiti, E., Athanasiadou, K. I., Kalampokas, T., Ψαλτοπούλου, Θ., Lambrinoudaki, I. V., Anastasiou, E., Wolffenbuttel, B. H. R., & Goulis, D. G. (2023) · Endocrine · doi:10.1007/s12020-023-03550-0 · Cited by 60
“Despite studies supporting metformin ’ s protective effect, most fail to establish this association [16 – 18, 24, 43 – 48].”
BackgroundInfluentialFetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS
Hjorth-Hansen, A., Salvesen, Ø., Engen Hanem, L. G., Eggebø, T., Salvesen, K. Å., Vanky, E., & Ødegård, R. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01191 · Cited by 47
Self-citationMetformin for pregnancy and beyond: the pros and cons
Newman, C., & Dunne, F. (2021) · Diabetic Medicine · doi:10.1111/dme.14700 · Cited by 49
Nardo, L. G., El‐Toukhy, T., Stewart, J. A., Balen, A. H., & Potdar, N. (2014) · Human Fertility · doi:10.3109/14647273.2015.985454 · Cited by 45
“A large Norwegian multi-centre RCT (Vanky et al., 2010) found no improvement in these complications with continued use of metformin throughout pregnancy, although there appeared to be a reduction in late miscarriage and pre-term delivery rates, which is now the subject of a large ongoing RCT.”
BackgroundMetformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach
Barbour, L. A., & Feig, D. S. (2019) · Diabetes Care · doi:10.2337/dci18-0055 · Cited by 44
Cognitive function in metformin exposed children, born to mothers with PCOS – follow-up of an RCT
Greger, H. K., Hanem, L. G. E., Østgård, H. F., & Vanky, E. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-1960-2 · Cited by 46
Self-citationPolycystic Ovary Syndrome and Insulin: Our Understanding in the Past, Present and Future
Mayer, S., Evans, W. S., & Nestler, J. E. (2015) · Women s Health · doi:10.2217/whe.14.73 · Cited by 60
Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function
Jorquera, G., Echiburú, B., Crisosto, N., Sotomayor‐Zárate, R., Maliqueo, M. A., & Cruz, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00653 · Cited by 49
Hyperandrogenism and Polycystic ovary syndrome: Effects in pregnancy and offspring development
Abruzzese, G. A., Silva, A. F., Velázquez, M. E., Ferrer, M., & Motta, A. B. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1558 · Cited by 51
Epigenetic inheritance of PCOS by developmental programming and germline transmission
Stener‐Victorin, E., & Deng, Q. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.12.002 · Cited by 42
Doi, S. A. R., Furuya‐Kanamori, L., Toft, E., Musa, O. A. H., Islam, N., Clark, J., & Thalib, L. (2020) · Obesity Reviews · doi:10.1111/obr.12964 · Cited by 39
Jamal, A. S., Milani, F., & Alyasin, A. (2012) · PubMed Central · Cited by 44
Kruse, B. C., & Vassar, M. B. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.10.007 · Cited by 39
Glueck, C. J., Goldenberg, N., Pranikoff, J., Khan, Z., Padda, J., & Wang, P. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.755121 · Cited by 39
Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT?
Andersen, M., & Glintborg, D. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0237 · Cited by 36
Gestational diabetes mellitus: Prevention, diagnosis and treatment. A fresh look to a busy corner
Zito, G., Corte, L. D., Giampaolino, P., Terzić, M., Terzic, S., Guardo, F. D., Ricci, G., Pietà, I. D., Maso, G., & Garzon, S. (2019) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-190305 · Cited by 43
Changes in Serum Cytokines Throughout Pregnancy in Women With Polycystic Ovary Syndrome
Stokkeland, L. M. T., Giskeødegård, G. F., Ryssdal, M., Jarmund, A. H., Steinkjer, B., Madssen, T. S., Stafne, S. N., Stridsklev, S., Løvvik, T. S., Iversen, A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab684 · Cited by 39
“Clinical Trial Information: The original studies are registered at http://www.clinicaltrials.gov with the following ClinicalTrials. gov identifier numbers: NCT00159536 (The PregMet study), NCT01587378 (The PregMet2 study) and NCT00476567 (The Training in Pregnancy study).”
BackgroundMethodSelf-citationMetformin in women with PCOS, Pros
Pasquali, R. (2014) · Endocrine · doi:10.1007/s12020-014-0311-1 · Cited by 39
Madhuvrata, P., Govinden, G., Bustani, R., Song, S. H., & Farrell, T. J. (2015) · Obstetric Medicine · doi:10.1177/1753495x15576673 · Cited by 41
Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome
Banaszewska, B., Pawelczyk, L. A., & Spaczyński, R. (2019) · Reproductive Biology · doi:10.1016/j.repbio.2019.09.006 · Cited by 43
Facchinetti, F., Cavalli, P., Copp, A. J., D’Anna, R., Kandaraki, E., Greene, N. D. E., Unfer, V., & for The Experts Group on Inositol in Basic and Clinical Research (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1828344 · Cited by 39
Metadata
- Authors
- Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., Berg, K. F., Bunford, G., Lund, A., Bjerke, C., Almås, I., Berg, A. H., Danielson, A., Lahmami, G., & Carlsen, S. M.
- Affiliations
- Norwegian University of Science and Technology (NO)
- St Olav's University Hospital (NO)
- Department of Public Health (P.R.) Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7489 Trondheim, Norway;
- Sentral Hospital of Northern Norway (K.S.), 8092 Bodø, Norway;
- Elvebredden Gynekologpraksis (O.K.), 4630 Kristiansand, Norway;
- Ålesund Hospital (NO)
- Stavanger University Hospital (P.v.B.), 4011 Stavanger, Norway;
- Haugesund Hospital (T.E.), 5504 Haugesund, Norway;
- UiT The Arctic University of Norway (NO)
- Drammen Hospital (NO)
- Ringerike Hospital (G.B.), 5311 Hønefoss, Norway;
- University of Bergen (NO)
- Lillehammer Hospital (C.B., A.H.B., A.D.), 2629 Lillehammer, Norway
- Buskerud Hospital (K.F.B., I.A.), 3004 Drammen, Norway;
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-12-01
- Volume
- 95
- Issue
- 12
- Pages
- E448-E455
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1986803895
- Cited by
- 315
- References
- 28
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 18 · 2023: 20 · 2022: 19 · 2021: 22 · 2020: 19 · 2019: 23 · 2018: 24 · 2017: 16 · 2016: 21 · 2015: 17 · 2014: 25 · 2013: 30 · 2012: 20
- FWCI
- 28.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Helse Midt-Norge
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- metformin, polycystic ovary syndrome, pregnancy complications, preeclampsia, gestational diabetes mellitus, preterm birth, gestational weight gain, birth weight, first trimester
- MeSH terms
- Adult, Blood Pressure, Double-Blind Method, Female, Heart Rate, Humans, Metformin, Patient Compliance, Placebos, Polycystic Ovary Syndrome, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Trimester, First, Random Allocation, Diabetes, Gestational, Delivery, Obstetric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.